The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papadakis, K. A.
Right arrow Articles by Targan, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papadakis, K. A.
Right arrow Articles by Targan, S. R.
The Journal of Immunology, 2005, 174: 4985-4990.
Copyright © 2005 by The American Association of Immunologists

Dominant Role for TL1A/DR3 Pathway in IL-12 plus IL-18-Induced IFN-{gamma} Production by Peripheral Blood and Mucosal CCR9+ T Lymphocytes1

Konstantinos A. Papadakis2, Daocheng Zhu, John L. Prehn, Carol Landers, Armine Avanesyan, Gina Lafkas and Stephan R. Targan2

Burns and Allen Research Institute, Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90048

The TNF-like cytokine TL1A augments IFN-{gamma} production by anti-CD3 plus anti-CD28 and IL-12/IL-18-stimulated peripheral blood (PB) T cells. However, only a small subset of PB T cells respond to TL1A stimulation with IFN-{gamma} production. PB CCR9+ T cells represent a small subset of circulating T cells with mucosal T cell characteristics and a Th1/Tr1 cytokine profile. In the current study, we show that TL1A enhanced IFN-{gamma} production by TCR- or CD2/CD28-stimulated CCR9+CD4+ PB T cells. However, TL1A had the most pronounced effect on augmenting IFN-{gamma} production by IL-12/IL-18-primed CCR9+CD4+ PB T cells. TL1A enhanced both the percentage and the mean fluorescence intensity of IFN-{gamma} in CCR9+CD4+ T cells as assessed by intracellular cytokine staining. IL-12 plus IL-18 up-regulated DR3 expression in CCR9+CD4+ T cells but had negligible effect on CCR9CD4+ T cells. CCR9+CD4+ T cells isolated from the small intestine showed a 37- to 105-fold enhancement of IFN-{gamma} production when TL1A was added to the IL-12/IL18 cytokine combination. Cell membrane-expressed TL1A was preferentially expressed in CCR9+CD4+ PB T cells, and a blocking anti-TL1A mAb inhibited IFN-{gamma} production by cytokine-primed CCR9+CD4+ T cells by ~50%. Our data show that the TL1A/DR3 pathway plays a dominant role in the ultimate level of cytokine-induced IFN-{gamma} production by CCR9+ mucosal and gut-homing PB T cells and could play an important role in Th1-mediated intestinal diseases, such as Crohn’s disease, where increased expression of IL-12, IL-18, TL1A, and DR3 converge in the inflamed intestinal mucosa.




This article has been cited by other articles:


Home page
IOVSHome page
J. Yamada, J. Hamuro, A. Fukushima, T. Ohteki, K. Terai, Y. Iwakura, H. Yagita, and S. Kinoshita
MHC-Matched Corneal Allograft Rejection in an IFN-{gamma}/IL-17-Independent Manner in C57BL/6 Mice
Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2139 - 2146.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. Kakuta, N. Ueki, Y. Kinouchi, K. Negoro, K. Endo, E. Nomura, S. Takagi, S. Takahashi, and T. Shimosegawa
TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells
Hum. Mol. Genet., March 15, 2009; 18(6): 1089 - 1098.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. J. Bull, A. S. Williams, Z. Mecklenburgh, C. J. Calder, J. P. Twohig, C. Elford, B. A. J. Evans, T. F. Rowley, T. J. Slebioda, V. Y. Taraban, et al.
The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis
J. Exp. Med., October 27, 2008; 205(11): 2457 - 2464.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. P. Pappu, A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al.
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
J. Exp. Med., May 12, 2008; 205(5): 1049 - 1062.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Cassatella, G. P. da Silva, I. Tinazzi, F. Facchetti, P. Scapini, F. Calzetti, N. Tamassia, P. Wei, B. Nardelli, V. Roschke, et al.
Soluble TNF-Like Cytokine (TL1A) Production by Immune Complexes Stimulated Monocytes in Rheumatoid Arthritis
J. Immunol., June 1, 2007; 178(11): 7325 - 7333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Prehn, L. S. Thomas, C. J. Landers, Q. T. Yu, K. S. Michelsen, and S. R. Targan
The T Cell Costimulator TL1A Is Induced by Fc{gamma}R Signaling in Human Monocytes and Dendritic Cells
J. Immunol., April 1, 2007; 178(7): 4033 - 4038.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Saruta, Q. T. Yu, A. Avanesyan, P. R. Fleshner, S. R. Targan, and K. A. Papadakis
Phenotype and Effector Function of CC Chemokine Receptor 9-Expressing Lymphocytes in Small Intestinal Crohn's Disease
J. Immunol., March 1, 2007; 178(5): 3293 - 3300.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-Y. Kim, K.-M. Toellner, A. White, F. M. McConnell, F. M. C. Gaspal, S. M. Parnell, E. Jenkinson, G. Anderson, and P. J. L. Lane
Neonatal and Adult CD4+CD3- Cells Share Similar Gene Expression Profile, and Neonatal Cells Up-Regulate OX40 Ligand in Response to TL1A (TNFSF15).
J. Immunol., September 1, 2006; 177(5): 3074 - 3081.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Bamias, M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli
From the Cover: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis
PNAS, May 30, 2006; 103(22): 8441 - 8446.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. A. Young and M. G. Tovey
TL1A: A mediator of gut inflammation
PNAS, May 30, 2006; 103(22): 8303 - 8304.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.